Mentoring Session - PowerPoint PPT Presentation

About This Presentation
Title:

Mentoring Session

Description:

The material presented in this session is for informational ... The use of an alternate QA/QC chemical in place of the Glucose/Glutamic Acid (GGA) for BOD/CBOD. ... – PowerPoint PPT presentation

Number of Views:12
Avg rating:3.0/5.0
Slides: 24
Provided by: Jer549
Category:

less

Transcript and Presenter's Notes

Title: Mentoring Session


1
Method Modifications
  • Mentoring Session
  • Technical Assistance Committee

2
TNI Training Disclaimer
  • The material presented in this session is for
    informational purposes only. It is designed to
    promote understanding, consistency and
    clarification of technical and accreditation
    requirements. It should not be considered a
    change or alteration of the Accreditation
    standards, the published methods, a regulatory
    agency requirement or a position of TNI.

3
Method Modifications
  • The primary objective of method
  • modifications is to enhance precision and
  • accuracy for each analysis.

4
  • All laboratories large and small
  • Such as commercial and private (including
    municipalities) must prove that their method
    modification to any approved standard analytical
    method is valid.

5
What to Document
  • The information and supporting data, required
    during the validation, must be sufficient to
    allow an independent reviewer (EPA, state or
    contractor) to verify each determination and
    calculation performed by the laboratory.

6
Modifications
  • Where more than one matrix type is involved
    (e.g., air, soil, water, sludge)
  • The laboratory must validate the method on each
    matrix type.
  • In most cases several different samples should be
    involved in the validation,
  • Example Non-Potable Water several effluent
    samples from different plants should be used.

7
Method Modifications
  • Validation Criteria
  • Must include the documented procedure used to
    validate and report the data
  • Should explain the statistical analysis of study
    results.
  • Must include all raw data results to allow for a
    complete independent reviewer verification
  • Should be checked by comparing the performance
    criteria with the actual approved standard
    method, as written.

8
Quality Control
  • What is involved?
  • Initial Precision and Recovery
  • Calibration (initial and continuing)
  • Method Detection Limit (MDL),
  • Laboratory fortified blank
  • Matrix Spikes
  • Method Blanks

9
Quality Control
  • Internal standard/s
  • Surrogate standard/s
  • Tracer (for radiochemistry)
  • Control charts or other trend analyses
  • Quality Control acceptance criteria

10
Raw Data
  • Sample numbers or other identifiers used
  • Sample preparation (extraction/digestion) dates
  • Analysis dates and times
  • Sequence of analyses or run logs
  • Sample volume

11
Raw Data
  • Extract volume prior to each cleanup step
  • Extract volume after each cleanup step
  • Final extract volume prior to injection
  • Digestion volume
  • Titration volume

12
Raw Data
  • Percent solids or percent moisture
  • Dilution data - differentiating between dilution
    of a sample and dilution of an extract
  • Instrument(s) and operating conditions, such as
  • GC and/or GC/MS including detailed
    information on columns used for determination and
    confirmation (column length and diameter,
    stationary phase, solid support, film thickness,
    etc.) In addition, analysis conditions
    (temperature programs, flow rates, etc.) must be
    documented
  • Detectors type, operating conditions, etc.
  • Chromatograms ion current profiles, bar graph
    spectra, library search results , etc

13
Raw Data
  • Data Quantitation reports, system outputs, and
    other data to link the raw data to the results
    reported. (Where these data are edited manually,
    explanations of all manual changes must be
    included)
  • Direct instrument readouts strip charts, printer
    tapes, etc., and other data to support the final
    results

14
Raw Data
  • Laboratory bench sheets and copies of all
    pertinent logbook pages for all sample
    preparation, cleanup, and determinative steps of
    the analysis
  • Dilution data - differentiating between dilution
    of a sample and dilution of an extract

15
Example 1
When using 1000 mL sample, the pipet used in the
method is a 25 mL wide bore, this would take an
analyst 40 separate measurements to deliver the
volme
  • Standard Methods 2540 D.
  • Total Suspended Solids
  • Sample Analysis
  • 3 (b) states to stir the sample and pipet an
    aliquot from the midpoint of the container

Modification Using a graduated cylinder (1000
ml) instead of the 25mL pipet, reduces analyst
time and handling of the sample
16
Example 2
  • The use of an alternate QA/QC chemical in place
    of the Glucose/Glutamic Acid (GGA) for BOD/CBOD.
  • Laboratories that are using KHP (Potassium
    Hydrogen Phthalate) for their BOD/CBOD depletion
    chemical.
  • Does the laboratory have the right to modify the
    method to a degree of changing the chemistry?

17
References
  • 40 CFR 136.6 Method modifications and
    analytical requirements.
  • Flexibility to Modify CWA Method Nov 20, 2007
  • EPA Solutions to Analytical Chemistry Problems
    with Clean Water Act Methods 2007 (Pumpkin Book)
  • (EPA 821-B-98-002 EPA Approval of Alternate Test
    Procedures for Organic and Inorganic Analytes in
    Wastewater and Drinking Water March 1999)

18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com